Logo-bi
Bioimpacts. 2020;10(3): 187-193. doi: 10.34172/bi.2020.23
PMID: 32793441        PMCID: PMC7416006

Original Research

Designing a light-activated recombinant alpha hemolysin for colorectal cancer targeting

Siamak Alizadeh 1,2, Abolfazl Barzegari 2, Abolghasem Esmaeili 1 * , Yadollah Omidi 2,3 * ORCID

Cited by CrossRef: 9




As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge